Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2018; 18(3):233-234
DOI: 10.5428/pcar20180321
Pharmaceutical care for a patient with refractory ulcerative colitis complicated with Clostridium difficile infection
1. LIU Tao(a bo.tao.1987@163.com)
2. YE YinMei(a 1335233425@qq.com)
Welcome to PCAR! You are the number 391 reader of this article!
Please cite this article as:
LIU Tao,YE YinMei,. Pharmaceutical care for a patient with refractory ulcerative colitis complicated with Clostridium difficile infection[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(3): 233-234.
References:
1. Ricciardi R,Ogilvie J W Jr,Roberts P L,et al.Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases[J].Dis Colon Rectum,2009,52(1):40-45.
2. Group of Inflammatory Bowel Diseases,Branch of Digestiology,Chinese Medical Association.Consensus on the diagnosis and treatment of inflammatory bowel diseases(2012,Guangzhou)[J].Chin J Intern Med,2012,51(10):818-831.In Chinese.
3. Musa S,Thomson S,Cowan M,et al.Clostridium difficile infection and inflammatory bowel diseases[J].Scand J Gastroenterol,2010,45(3):261-272.
4. Powell N,Jung S E,Krishnan B.Clostridium difficile infection and inflammatory bowel diseases:a marker for disease extent?[J].Gut,2008,57(8):1183-1184.
5. Trubiano J A,Cheng A C,Korman T M,et al.Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand[J].Intern Med J,2016,46(4):479-493.
6. Negrón M E,Rezaie A,Barkema H W,et al. Ulcerative colitis patients with Clostridium difficile are at increased risk of death,colectomy,and postoperative complications:a population-based inception cohort study[J].Am J Gastroenterol,2016,111(6):691-704.
7. JIA TianYe,TANG YiWei,QU Fen.Key points of American guidelines for the diagnosis and treatment of Clostridium difficile infection[J].Infect Dis Inf,2015,28(4):193-196.In Chinese with English abstract.
8. Wombwell E,Chittum M E,Leeser K R.Inpatient proton pump inhibitor administration and hospital-acquired Clostridium difficile infection:evidence and possible mechanism[J].Am J Med,2018,131(3):244-249.
9. Surawicz C M,Brandt L J,Binion D G,et al.Guidelines for diagnosis,treatment, and prevention of Clostridium difficile infections[J].Am J Gastroenterol,2013,108(4):478-498.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口